1. Market Research
  2. > Healthcare Market Trends
  3. > Impact of Policies Shaping ASEAN Healthcare—Outlook till 2020

Impact of Policies Shaping ASEAN Healthcare—Outlook till 2020

  • September 2015
  • -
  • Frost & Sullivan
  • -
  • 137 pages

Impact of Policies Shaping ASEAN Healthcare—Outlook till 2020 : Policies Raising Standards and Lowering Barriers Across ASEAN

Executive Summary

Impact of Policy making in ASEAN

The policies in the ASEAN nations are directed toward creating a single ASEAN market. Although this will be achieved through national initiatives that allow increased competition among the member nations’ markets, small and medium enterprises (SMEs) and large local corporations will need to drive the initiatives. Frost & Sullivan believes the opportunities provided by the initiatives can spur market growth and diversification. The opportunities will still not be equal among the countries, as each member nation will still decide which of its own market sectors it will open up or protect. Nevertheless, the reduction of entry barriers and business facilitation across borders promoting intra-ASEAN trade and expansion are reshaping the ASEAN healthcare market environment creating unique environments that allow different stakeholders to thrive.

National policies in the ASEAN region are bridging the countries together while protecting national interests of individual nations.

Key policies impacting the healthcare industry in the ASEAN region:

- ASEAN Economic Community
- ASEAN Medical Device Directive - Universal Health Coverage–Indonesia
- E-Catalogue–Indonesia
- Medical Hub Aimed Policies–Thailand
- Companies Act 2015 – Myanmar


Table Of Contents

Impact of Policies Shaping ASEAN Healthcare—Outlook till 2020
Table Of Contents
1 EXECUTIVE SUMMARY

Executive Summary
1 Executive Summary
2 Status of top 6 Policies Implementation
3 Ranking
4 Top 6 Policies Key Take Away
5 Policy Impact Forecast
6 ASEAN Policy Impact—Growth Forecast
7 ASEAN Policy Impact—Growth Forecast
8 ASEAN Indices
9 ASEAN Policy Impact—Current Indices
10 Indices Disparity Forecast Trend
11 ASEAN Indices Forecast
12 Current Indices and Policies
13 CEO's Perspective

2 INTRODUCTION

Introduction
1 Introduction

3 BACKGROUND

Background
1 Background of Healthcare Policy Changes in ASEAN Countries
2 Background of Healthcare Policy Changes in ASEAN Countries
3 Background of Healthcare Policy Changes in ASEAN Countries
4 Background of Healthcare Policy Changes in ASEAN Countries

4 RESEARCH METHODOLOGY

Research Methodology
1 Scope of Research
2 Research Methodology
3 Research Methodology
4 Research Methodology

5 KEY POLICY I—ASEAN ECONOMIC COMMUNITY (AEC)

Key Policy I—ASEAN Economic Community (AEC)
1 Key Policy I—ASEAN Economic Community
2 Key Policy I—Policy Changes in ASEAN Countries for AEC
3 Key Policy I—Current AEC Scenario
4 Key Policy I—Policies in ASEAN Countries Affected by AEC
5 Key Policy I—Drivers and Restraints
6 Key Policy I—Intra- and Extra-ASEAN FDI
7 Key Policy I—AEC Barriers
8 AEC Impact Analysis—Public Hospitals
9 AEC Impact Analysis—Private Hospitals
10 AEC Impact Analysis—Medical Devices
11 AEC Impact Analysis—Diagnostic Services
12 AEC Impact Analysis—Pharmaceutical
13 AEC Impact Analysis—Distributors
14 AEC Impact Analysis—Insurers
15 AEC Impact Analysis—Healthcare IT
16 Key Policy I—AEC Market Impact

6 KEY POLICY II—ASEAN MEDICAL DEVICE DIRECTIVE (AMDD)

Key Policy II—ASEAN Medical Device Directive (AMDD)
1 Key Policy II—ASEAN Medical Device Directive
2 Key Policy II—ASEAN Medical Device Directive
3 Key Policy II—ASEAN Medical Device Directive and its Implication to Policy Making
4 Key Policy II—ASEAN Medical Device Directive and its Implication on Policy Making
5 Key Policy II—Drivers and Restraints
6 AMDD Impact Analysis—Hospital
7 AMDD Impact Analysis—Medical Devices
8 AMDD Impact Analysis—Diagnostic Services
9 AMDD Impact Analysis—Distributors
10 AMDD Impact Analysis—Health Insurance
11 AMDD Impact Analysis—Healthcare IT
12 Key Policy II—AMDD Market Impact

7 KEY POLICY III—UNIVERSAL HEALTH COVERAGE (UHC)

Key Policy III—Universal Health Coverage (UHC)
1 Key Policy III—Universal Health Coverage
2 Key Policy III—Universal Health Coverage
3 Key Policy III—Universal Health Coverage
4 Key Policy III—Universal Health Coverage
5 Key Policy III—Universal Health Coverage
6 Key Policy III—Universal Health Coverage
7 Key Policy III—Expenditure Trends during UHC Implementation in ASEAN
8 Key Policy III—Expenditure Trends during UHC Implementation in ASEAN
9 Key Policy III—Indonesian Market Prediction for UHC Impact
10 Key Policy III—Drivers and Restraints
11 Key Policy III—Indonesian UHC Impact Details
12 UHC Impact Analysis—Public Hospitals
13 UHC Impact Analysis—Private Hospitals
14 UHC Impact Analysis—Medical Devices and Diagnostic Services
15 UHC Impact Analysis—Pharmaceutical
16 UHC Impact Analysis—Distributors
17 UHC Impact Analysis—Health Insurance
18 UHC Impact Analysis—Healthcare IT
19 Key Policy III—UHC Market Impact

8 KEY POLICY IV—ONLINE-CATALOGUE AND PURCHASING SYSTEM (E-CATALOGUE)

Key Policy IV—Online-Catalogue and Purchasing System (E-Catalogue)
1 Key Policy IV—E-Catalogue
2 Key Policy IV—E-Catalogue
3 Key Policy IV—E-Catalogue and the E-Procurement value chain in Indonesia
4 Key Policy IV—Drivers and Restraints
5 Key Policy IV—Existing Ground Level Barriers to E-Catalogue
6 Key Policy IV—E-Catalogue and its Future
7 E-Catalogue Impact Analysis—Public Hospitals
8 E-Catalogue Impact Analysis—Private Hospitals
9 E-Catalogue Impact Analysis—Medical Devices
10 E-Catalogue Impact Analysis—Medical Service Providers
11 E-Catalogue Impact Analysis—Distributors
12 Key Policy IV—E-Catalogue Market Impact

9 KEY POLICY V—MEDICAL HUB AIMED POLICIES

Key Policy V—Medical Hub Aimed Policies
1 Key Policy V—Medical Hub Aimed Policies
2 Key Policy V—Medical Hub Aimed Policies
3 Key Policy V—Medical Tourism
4 Key Policy V—Medical Hub Promotion
5 Key Policy V—Medical Hub Investment Grouping
6 Key Policy V—Medical Hub Investment Benefits
7 Key Policy V—Medical Hub Aimed: Other Developments
8 Key Policy V—Drivers and Restraints
9 Medical Hub Aimed Policies Impact Analysis—Public Hospitals
10 Medical Hub Aimed Policies Impact Analysis—Private Hospitals
11 Medical Hub Aimed Policies Impact Analysis—Medical Devices
12 Medical Hub Aimed Policies Impact Analysis—Diagnostic Services
13 Medical Hub Aimed Policies Impact Analysis— Pharmaceutical
14 Medical Hub Aimed Policies Impact Analysis—Healthcare IT
15 Key Policy V—Medical Hub Aimed Policies Market Impact

10 KEY POLICY VI—MYANMAR COMPANIES ACT 2015

Key Policy VI—Myanmar Companies Act 2015
1 Key Policy VI—Myanmar Companies Act 2015
2 Key Policy VI—Myanmar Companies Act 2015
3 Key Policy VI—Modern Law
4 Key Policy VI—Law Reform
5 Key Policy VI—Investment Benefits
6 Key Policy VI—Healthcare Reform
7 Key Policy VI—Market Growth
8 Key Policy VI—Drivers and Restraints
9 Myanmar Companies Act 2015 Impact Analysis—Public Hospitals
10 Myanmar Companies Act 2015 Impact Analysis—Private Hospitals
11 Myanmar Companies Act 2015 Market Impact— Pharmaceutical
12 Myanmar Companies Act 2015 Impact Analysis—Medical Devices
13 Myanmar Companies Act 2015 Impact Analysis—Diagnostic Services
14 Myanmar Companies Act 2015 Impact Analysis—Health Information Technology
15 Myanmar Companies Act 2015 Impact Analysis—Health Insurance
16 Key Policy VI—Myanmar Companies Act 2015 Market Impact

11 KEY POLICIES IMPACTING ASEAN—OPPORTUNITIES IN ASEAN 2015 TO 2020

Key Policies Impacting ASEAN—Opportunities in ASEAN 2015 to 2020
1 Market Analysis—ASEAN Policy Impacts as a Whole
2 ASEAN Policy Impact
3 ASEAN Policy Impact—Free Trade
4 ASEAN Policy Impact—Infrastructure
5 ASEAN Policy Impact—Human Resource
6 ASEAN Policy Impact—Another European Union?
7 The Future of ASEAN
8 Legal Disclaimer

12 APPENDIX

Appendix
1 Appendix 1—ASEAN FDI Activity in Healthcare (AEC)
2 Appendix 2—ASEAN FDI Activity in Healthcare (AEC)
3 List of Abbreviations

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.